๐๏ธ Verified NIH Record โข Updated 2026-05-19
COVID-19 Biorepository (NCT04568148)
๐ต Active, Not Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: University of Kansas Medical Center
๐ฉบ Plain-English Summary (8th-Grade Level)
Establish a COVID-19 biorepository to aid in developing our knowledge of the disease.
Who can join: Review the eligibility criteria below.
Location: University of Kansas Medical Center โ Kansas City, Kansas
Age range: 18 Years
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- University of Kansas Medical Center โ Kansas City, Kansas
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Covid-19
- COVID-19 and Cancer Consortium Registry โ Nashville, Tennessee
- Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients โ Sacramento, California
- COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE) โ Bethesda, Maryland
- Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans โ Baltimore, Maryland
- Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings โ Calgary, Alberta
- A Nasal Treatment for COVID-19 โ Indianapolis, Indiana
Explore by condition: All Covid-19 clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.